Keywords
SARS-CoV-2
Prevalencia
Trabajadores de la salud Coronavirus infections
SARS-CoV-2
Prevalence
Health personnel
Population
Población.
How to Cite
Abstract
Purpose: To establish the seroprevalence of anti-SARS-CoV-2 IgG and IgM antibodies in the general population, healthcare workers, and students in Bogotá. Methods: Observational cross-sectional study conducted between March and May 2021 at different fourth-level health care networks. Data was collected from health personnel care, as well as from the general population. Qualitative detection of serum IgG and IgM antibodies against SARS CoV2 in humans was performed using a rapid immunochromatographic test. Seropositivity was defined as a positive IgG or IgM antibody result. The proportion of positive cases was reported as a percentage with its 95%CI, adjusted for sensitivity (97.5%) and specificity (92.8%) of the test as reported by the manufacturer. Results: 1651 participants were included, of which 58.5% corresponded to health human talent, 75.7% were women, 62.0% belong to socio-economic strata (strata 3 and 4) and, 21.3% resided in the Suba locality. The adjusted seroprevalence in general population (n=288) was 25.91% (IC95% 20.59-31.24)] and in human talent in health (n=210) 25.03% (IC95% 18.84-31.21). Discussion: the proportion of seroprevalence is subject to the timing of the pandemic and also to the type of test applied to detect SARS-CoV-2 antibodies. Conclusions: The adjusted seroprevalence in both populations was around 25% and is similar to that reported by the National Institute of Health (Bogota 30%; 95%CI 27 - 33%) between 26 October and 17 November 2020.
References
Ariza, B., Torres, X., Salgado, D., Cepeda, M., Restrepo, C., Castellanos, J., Suárez-Obando, F., Cuellar, A., Cardozo-Romero, C., Ángel, J., Franco, M., Ignacio, S., & Colombia, B. (2020). Seroprevalence and seroconversion rates to SARS-CoV-2 in interns, residents, and medical doctors in a. https://doi.org/10.1101/2020.09.15.20195313
Batchi-Bouyou, A. L., Lobaloba Ingoba, L., Ndounga, M., Vouvoungui, J. C., Mfoutou Mapanguy, C. C., Boumpoutou, K. R., & Ntoumi, F. (2021). High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo. International Journal of Infectious Diseases, 106, 3–7. https://doi.org/10.1016/j.ijid.2020.12.065
Bergeri, I., Whelan, M., Ware, H., Subissi, L., Nardone, A., Lewis, H. C., Li, Z., Ma, X., Valenciano, M., Cheng, B., Ariqi, L. Al, Rashidian, A., Okeibunor, J., Azim, T., Wijesinghe, P., Le, L.-V., Vaughan, A., Pebody, R., Vicari, A., … Van Kerkhove, M. D. (2022). Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022. MedRxiv, 2021.12.14.21267791. https://doi.org/10.1101/2021.12.14.21267791
Caballero, N., Nieto, M. A., Suarez-Zamora, D. A., Moreno, S., Remolina, C. I., Durán, D., Vega, D., Rodríguez-Urrego, P. A., Gómez, C. P., Rojas, D. P., Ramírez, A., Martínez, O., Baldión-Elorza, A. M., Hernández, L. J., & Quintero, J. (2022). Prevalence of SARS-CoV-2 infection and SARS-CoV-2-specific antibody detection among healthcare workers and hospital staff of a university hospital in Colombia. IJID Regions, 3, 150–156. https://doi.org/https://doi.org/10.1016/j.ijregi.2022.03.013
Clarke, K. E. N., Jones, J. M., Deng, Y., Nycz, E., Lee, A., Iachan, R., Gundlapalli, A. V, Hall, A. J., & Macneil, A. (2022). Morbidity and Mortality Weekly Report Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies-United States, September 2021-February 2022. 71(17), 2021–2023. https://www.medrxiv.org/content/10.1101/2022.04.18.22271936v1?rss
Colmenares-Mejía, C. C., Serrano-Díaz, N., Quintero-Lesmes, D. C., Meneses, L., Salazar Acosta, I., Idrovo, Á. J., Sanabria-Echeverry, D. Y., Cordero-Rebolledo, H., & Castillo, V. (2021). Seroprevalence of SARS-CoV-2 Infection among Occupational Groups from the Bucaramanga Metropolitan Area, Colombia. International Journal of Environmental Research and Public Health, 18(8). https://doi.org/10.3390/ijerph18084172
de Visscher, N., Holemans, X., Gillain, A., Kornreich, A., Lagasse, R., Piette, P., Ventura, M., & Thys, F. (2022). SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves. Viruses, 14(7). https://doi.org/10.3390/v14071535
Figueiredo-Campos, P., Blankenhaus, B., Mota, C., Gomes, A., Serrano, M., Ariotti, S., Costa, C., Nunes-Cabaço, H., Mendes, A. M., Gaspar, P., Pereira-Santos, M. C., Rodrigues, F., Condeço, J., Escoval, M. A., Santos, M., Ramirez, M., Melo-Cristino, J., Simas, J. P., Vasconcelos, E., … Veldhoen, M. (2020). Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset. European Journal of Immunology, 50(12), 2025–2040. https://doi.org/10.1002/eji.202048970
Galanis, P., Vraka, I., Fragkou, D., Bilali, A., & Kaitelidou, D. (2021). Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. The Journal of Hospital Infection, 108, 120–134. https://doi.org/10.1016/j.jhin.2020.11.008
Gelanew, T., Seyoum, B., Mulu, A., Mihret, A., Abebe, M., Wassie, L., Gelaw, B., Sorsa, A., Merid, Y., Muchie, Y., Teklemariam, Z., Tesfaye, B., Osman, M., Jebessa, G., Atinafu, A., Hailu, T., Habte, A., Kenea, D., Gadissa, A., … Abdissa, A. (2021). High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers. In Research square. https://doi.org/10.21203/rs.3.rs-676935/v1
Gonzalez, J., Santos-Barbosa, J., Jaller, C., Otalora, G., Hernandez, L., Guevara-Suarez, M., & Restrepo, S. (2021). Seroreactivity to SARS-CoV-2 in individuals attending a university campus in Bogota Colombia. https://doi.org/10.1101/2021.03.15.21253609
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O’Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., & Duda, S. N. (2019). The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics, 95, 103208. https://doi.org/10.1016/j.jbi.2019.103208
Idrovo, Á. J., Moreno-Montoya, J., & Pinzón-Flórez, C. E. (2020). Desempeño de las pruebas combinadas de IgM e IgG rápidas en la vigilancia ocupacional de COVID-19 en empresas colombianas. Biomédica, 40(Supl. 2 SE-Artículos originales), 139–147. https://doi.org/10.7705/biomedica.5829
Malagón-Rojas, J. N., Mercado-Reyes, M., Toloza-Pérez, Y. G., Parra Barrera, E. L., Palma, M., Muñoz, E., López, R., Almentero, J., Rubio, V. V, Ibáñez, E., Téllez, E., Delgado-Murcia, L. G., Jimenez, C. P., Viasus-Pérez, D., Galindo, M., & Lagos, L. (2022). Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities. Occupational and Environmental Medicine, 79(6), 388–395. https://doi.org/10.1136/oemed-2021-107487
Mercado-Reyes, M., Malagón-Rojas, J., Rodríguez-Barraquer, I., Zapata-Bedoya, S., Wiesner, M., Cucunubá, Z., Toloza-Pérez, Y. G., Hernández-Ortiz, J. P., Acosta-Reyes, J., Parra-Barrera, E., Ibáñez-Beltrán, E., Quinche, G. G., Muñoz-Galindo, L., Rubio, V., Galindo-Borda, M., Osorio-Velázquez, E. G., Bermúdez-Forero, A., Pinto-Chacón, N., Puerto-Castro, G., … Ospina-Martínez, M. (2022). Seroprevalence of anti-SARS-CoV-2 antibodies in Colombia, 2020: A population-based study. The Lancet Regional Health - Americas, 9, 1–12. https://doi.org/10.1016/j.lana.2022.100195
Paduano, S., Galante, P., Berselli, N., Ugolotti, L., Modenese, A., Poggi, A., Malavolti, M., Turchi, S., Marchesi, I., Vivoli, R., Perlini, P., Bellucci, R., Gobba, F., Vinceti, M., Filippini, T., & Bargellini, A. (2022). Seroprevalence Survey of Anti-SARS-CoV-2 Antibodies in a Population of Emilia-Romagna Region, Northern Italy. International Journal of Environmental Research and Public Health, 19(13), 1–11. https://doi.org/10.3390/ijerph19137882
Poletti, P., Tirani, M., Cereda, D., Guzzetta, G., Trentini, F., Marziano, V., Toso, C., Piatti, A., Piccarreta, R., Melegaro, A., Andreassi, A., Gramegna, M., Ajelli, M., & Merler, S. (2021). Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy. JAMA Network Open, 4(7), e2115699–e2115699. https://doi.org/10.1001/jamanetworkopen.2021.15699
Poustchi, H., Darvishian, M., Mohammadi, Z., Shayanrad, A., Delavari, A., Bahadorimonfared, A., Eslami, S., Javanmard, S. H., Shakiba, E., Somi, M. H., Emami, A., Saki, N., Hormati, A., Ansari-Moghaddam, A., Saeedi, M., Ghasemi-Kebria, F., Mohebbi, I., Mansour-Ghanaei, F., Karami, M., … Malekzadeh, R. (2021). SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. The Lancet Infectious Diseases, 21(4), 473–481. https://doi.org/10.1016/S1473-3099(20)30858-6
Pradhan, M., Shah, K., Alexander, A., Ajazuddin, Minz, S., Singh, M. R., Singh, D., Yadav, K., & Chauhan, N. S. (2022). COVID-19: clinical presentation and detection methods. Journal of Immunoassay and Immunochemistry, 43(1). https://doi.org/10.1080/15321819.2021.1951291
Ranjbar Kermani, F., Arabkhazaeli, A., Eshghi, P., Maghsudlu, M., Amini-Kafiabad, S., Teimourpour, A., & Pourkarim, M. R. (2022). Estimate of anti-SARS-CoV-2 spike IgG antibodies prevalence among Iranian population based on blood donations: A serial cross-sectional study during the third wave of the pandemic. Transfusion Clinique et Biologique : Journal de La Societe Francaise de Transfusion Sanguine. https://doi.org/10.1016/j.tracli.2022.09.003
Rosselli, D. (2020). Covid-19 en Colombia: los primeros 90 días. Acta Neurológica Colombiana, 36(2 Supl. 1), 1–6. https://doi.org/10.22379/24224022287
Salud, I. N. de. (2022a). Estudio Nacional de Seroprevalencia. https://www.ins.gov.co/estudio-nacional-de-seroprevalencia/reporte.html
Salud, I. N. de. (2022b). Noticias coronavirus casos. https://www.ins.gov.co/Noticias/Paginas/coronavirus-casos.aspx
Salud, I. N. de, & Salud, O. P. de la. (2021). Reporte de la situación COVID-19 Colombia. Mayo 4 de 2021. https://www.paho.org/es/documentos/reporte-situacion-covid-19-colombia-no-219-04-mayo-2021
SEROTRACKER. (2022). Gobal Seroprevalence. https://serotracker.com/
STROBE. (n.d.). STROBE - Strengthening the reporting of observational studies in epidemiology [Internet]. Retrieved July 19, 2022, from https://www.strobe-statement.org/
World-Health-Organization. (2022a). Interim statement on hybrid immunity and increasing population seroprevalence rates. https://www.who.int/news/item/01-06-2022-interim-statement-on-hybrid-immunity-and-increasing-population-seroprevalence-rates
World-Health-Organization. (2022b). WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/